These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15207678)

  • 1. Oral misoprostol vs. vaginal misoprostol for termination of pregnancy with intrauterine fetal demise in the second-trimester.
    Fadalla FA; Mirghani OA; Adam I
    Int J Gynaecol Obstet; 2004 Jul; 86(1):52-3. PubMed ID: 15207678
    [No Abstract]   [Full Text] [Related]  

  • 2. Sublingual compared with oral and vaginal misoprostol for termination of pregnancy with second-trimester fetal demise.
    Elhassan EM; Abubaker MS; Adam I
    Int J Gynaecol Obstet; 2008 Jan; 100(1):82-3. PubMed ID: 17888920
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT; Papatsonis DN; Heydanus R
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose vaginal misoprostol in the management of intrauterine fetal death.
    El-Gharib MN; Elebyary MT
    J Matern Fetal Neonatal Med; 2011 Oct; 24(10):1239-42. PubMed ID: 21714693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misoprostol for termination of pregnancy with intrauterine fetal demise in the second and third trimester of pregnancy - a systematic review.
    Gómez Ponce de León R; Wing DA
    Contraception; 2009 Apr; 79(4):259-71. PubMed ID: 19272495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of two regimens of misoprostol for early second-trimester pregnancy termination.
    Guix C; Palacio M; Figueras F; Bennasar M; Zamora L; Coll O; Cararach V
    Fetal Diagn Ther; 2005; 20(6):544-8. PubMed ID: 16260893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal vs. oral misoprostol for mid-trimester abortion.
    Nigam A; Singh VK; Prakash A
    Int J Gynaecol Obstet; 2006 Mar; 92(3):270-1. PubMed ID: 16430901
    [No Abstract]   [Full Text] [Related]  

  • 8. Second trimester pregnancy termination with 400 μg vaginal misoprostol: efficacy and safety.
    Kunwar S; Saha PK; Goel P; Huria A; Tandon R; Sehgal A
    Biosci Trends; 2010 Dec; 4(6):351-4. PubMed ID: 21248435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion.
    Ellis SC; Kapp N; Vragpvoc O; Borgata L
    Contraception; 2010 May; 81(5):441-5. PubMed ID: 20399952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death.
    Chittacharoen A; Herabutya Y; Punyavachira P
    Obstet Gynecol; 2003 Jan; 101(1):70-3. PubMed ID: 12517648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal versus oral misoprostol for second-trimester pregnancy termination: a randomized trial.
    Behrashi M; Mahdian M
    Pak J Biol Sci; 2008 Nov; 11(21):2505-8. PubMed ID: 19205272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthropometric characteristics and success rates of oral or vaginal misoprostol for pregnancy termination in the first and second trimesters.
    van Bogaert LJ; Misra A
    Int J Gynaecol Obstet; 2010 Jun; 109(3):213-5. PubMed ID: 20206352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two dose regimens of misoprostol for second-trimester pregnancy termination.
    Brouns JF; van Wely M; Burger MP; van Wijngaarden WJ
    Contraception; 2010 Sep; 82(3):266-75. PubMed ID: 20705156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate for the termination of second trimester pregnancy: a prospective, open-label, randomized clinical trial.
    Hou S; Chen Q; Zhang L; Fang A; Cheng L
    Eur J Obstet Gynecol Reprod Biol; 2010 Aug; 151(2):149-53. PubMed ID: 20434827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing the abortion interval of second trimester pregnancy termination using misoprostol.
    Ting WH; Peng FH; Lin HH; Lu HF; Hsiao SM
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):408-11. PubMed ID: 26384060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal misoprostol versus intravenous oxytocin for the management of second-trimester pregnancies with intrauterine fetal death: A randomized clinical trial.
    Abediasl Z; Sheikh M; Pooransari P; Farahani Z; Kalani F
    J Obstet Gynaecol Res; 2016 Mar; 42(3):246-51. PubMed ID: 26663590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of vaginal misoprostol versus vaginal misoprostol and isosorbide dinitrate for termination of pregnancy at 13-29 weeks.
    Hidar S; Bouddebous M; Chaïeb A; Jerbi M; Bibi M; Khaïri H
    Arch Gynecol Obstet; 2005 Dec; 273(3):157-60. PubMed ID: 16041629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
    Tang OS; Lau WN; Chan CC; Ho PC
    BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: Worth the effort.
    Dickinson JE; Brownell P; McGinnis K; Nathan EA
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):60-4. PubMed ID: 20218999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interruption of nonviable pregnancies of 24-28 weeks' gestation using medical methods: release date June 2013 SFP guideline #20133.
    Perritt JB; Burke A; Edelman AB
    Contraception; 2013 Sep; 88(3):341-9. PubMed ID: 23756114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.